Note: We will prioritize shipping the format currently in stock. However, if you have specific format requirements, please specify them during order placement. We will accommodate your request to the best of our ability.
Note: All proteins are shipped with standard blue ice packs. If dry ice shipping is required, please contact us in advance; additional fees will apply.
The tag type will be determined during the production process. If you require a specific tag type, please inform us, and we will prioritize its development.
Recombinant Human Keratin, type I cytoskeletal 26 (KRT26) is a protein belonging to the keratin superfamily. It has the following properties:
Molecular Weight: Approximately 51.7 kDa
Genomic Location: Chromosome 17q21.2, existing in a cluster with other keratin genes
Expression: Primarily specific for the inner root sheath of the hair follicle
Alternative Names: Cytokeratin 26, CK26, K25, K26, KRT25B, K25IRS2
NCBI Accession: NP_853517
When produced as a recombinant protein, it typically contains a purification tag (commonly His-tag) and is expressed in expression systems such as Escherichia coli .
Verification of recombinant KRT26 involves multiple analytical techniques:
SDS-PAGE and Coomassie Blue Staining: For purity assessment (typically >80% purity is considered acceptable for research applications)
Western Blotting: For identity confirmation using specific antibodies against KRT26 or the attached tag
Mass Spectrometry: For protein identity verification and detection of post-translational modifications
End-Sequencing: Of the ORF clone used for expression to confirm sequence integrity
Analytical SEC (HPLC): For higher resolution purity assessment and evaluation of oligomeric state
For recombinant KRT26 with His-tag, additional validation may include anti-tag ELISA to verify tag accessibility and functionality .
Recombinant KRT26 protein has several key applications in research:
Native Antigen Source: Serves as an optimal antigen for antibody production against KRT26
Positive Control: Acts as a standard in ELISA, Western blot, and other antibody-based assays
Functional Studies: Investigating protein-protein interactions involving KRT26
Structural Analysis: Understanding the structural properties of type I keratins
Neurodevelopmental Research: Exploring potential roles in autism spectrum disorders based on identified genetic variants
Hair Follicle Biology: Studying inner root sheath development and hair morphogenesis
Animal Science: Investigating associations with hair/fiber quality in livestock
To effectively study KRT26 polymorphisms and their phenotypic associations:
Experimental Design Framework:
Population Selection:
Choose appropriate populations with measurable phenotypic variation
Consider adequate sample sizes for statistical power (typically >100 individuals)
Include diverse genetic backgrounds when applicable
Genotyping Approach:
PCR-Seq polymorphism detection
Sequence alignment for SNP identification
Focus on functional regions (exons, promoters, regulatory elements)
Phenotypic Measurements:
Standardize collection methods
Include multiple relevant traits (e.g., hair parameters)
Use quantitative and qualitative assessments
Statistical Analysis:
Association testing using SPSS or similar software
Haplotype analysis for combined genetic effects
Correction for multiple testing and population stratification
Example Study Design: In a study examining KRT26 in cashmere goats, researchers identified two significant SNPs (A559T and A6839G) through sequence alignment and PCR-Seq polymorphism analysis. The AA genotype at the KRT26 A559T locus was identified as the dominant genotype, and this specific genotype was associated with finer cashmere fibers, providing a marker for selective breeding programs .
Storage and Handling Protocol:
| Parameter | Recommended Condition | Notes |
|---|---|---|
| Storage Temperature | -80°C | Critical for long-term stability |
| Buffer Composition | 25 mM Tris, pH 8.0, 150 mM NaCl, 10% glycerol, 1% Sarkosyl | Maintains protein solubility |
| Aliquoting | Single-use aliquots after initial thaw | Minimizes freeze-thaw damage |
| Freeze-Thaw Cycles | Maximum 2-3 cycles | More cycles significantly reduce activity |
| Working Conditions | Keep on ice during experiments | Prevents degradation |
| Concentration | Typically supplied at 50 μg/mL | May require adjustment for specific applications |
| Stability Period | At least 3 months from receipt | Under proper storage conditions |
When thawing, allow protein to thaw completely on ice before use. Avoid repeated freeze-thaw cycles as they can lead to protein degradation, aggregation, and loss of function .
When full experimental control isn't possible (especially in human studies), quasi-experimental designs offer viable alternatives:
Time-Series Design:
Monitor KRT26 expression during different stages of hair follicle development
Take measurements at regular intervals using ex vivo hair follicle models
Analyze temporal changes in expression patterns
Non-Equivalent Control Group Design:
Compare tissues with different levels of KRT26 expression
Match samples based on relevant characteristics (age, sex, hair type)
Control for confounding variables through statistical methods
Regression Discontinuity Design:
Focus on threshold effects in KRT26 expression levels
Assign samples to groups based on quantitative expression cutoffs
Analyze differences in hair development outcomes
Methodological Controls:
Include positive and negative tissue controls
Use siRNA knockdown or CRISPR/Cas9 for KRT26 manipulation
Employ multiple detection methods (IHC, qPCR, Western blot)
These quasi-experimental approaches help maximize internal validity while acknowledging the practical constraints of studying human keratin biology .
Current Evidence Base:
Genetic Association Studies:
Rare inherited loss-of-function and damaging missense variants identified in ASD probands from:
Simons Simplex Collection (Krumm et al., 2015)
Cohort of Chinese ASD probands (Li J et al., 2017)
Transmission and De Novo Association (TADA) analysis identified KRT26 as an ASD candidate gene with PTADA of 0.005182
Specific Variants Identified:
| Allele Change | Residue Change | Variant Type | Inheritance | Study |
|---|---|---|---|---|
| c.43C>T | p.Arg15Ter | Stop-gained | De novo | Zhou X et al. (2022) |
| c.1060G>T | p.Glu354Ter | Stop-gained | Familial | Li J et al. (2017) |
| c.277C>T | p.Arg93Cys | Missense | Familial | Li J et al. (2017) |
| G>T | p.Ser37Ter | Stop-gained | Paternal | Krumm N et al. (2015) |
Functional Implications:
Experimental Framework for Functional Studies:
In Vitro Neuronal Models:
Neural progenitor cells derived from patient iPSCs carrying KRT26 variants
CRISPR/Cas9 engineered cell lines with specific KRT26 variants
Isogenic control lines to minimize background genetic effects
Experimental Readouts:
Neuronal differentiation markers and morphology
Synapse formation and electrophysiological properties
Protein localization and interaction network analyses
Transcriptomic and proteomic profiling
Rescue Experiments:
Re-expression of wild-type KRT26 in variant-containing cells
Downstream pathway modulation to identify intervention points
Small molecule screening for phenotypic rescue
Animal Models:
KRT26 knockout or variant knock-in models
Behavioral assessments relevant to ASD symptomatology
Histological examination of brain development and architecture
Controls and Validation:
Multi-level Expression Analysis Methodology:
Transcriptional Analysis:
RNA-Seq for quantitative expression across tissues
Single-cell RNA-Seq for cellular resolution
qRT-PCR for targeted expression quantification
In situ hybridization for spatial localization
Protein-Level Detection:
Immunohistochemistry (IHC) for tissue localization
Fluorescence microscopy for subcellular localization
Western blotting for protein size verification
Mass spectrometry for proteoform identification
High-Resolution Anatomical Mapping:
Laser capture microdissection combined with expression analysis
Spatial transcriptomics for regional expression patterns
Multiplexed immunofluorescence for co-expression studies
Current data indicate that KRT26 expression shows tissue specificity with primary expression in the hair follicle inner root sheath. The Human Protein Atlas data demonstrates restricted expression patterns across brain regions and other tissues, with notable absence in many common tissue types .
Experimental Strategy for Resolving Contradictions:
Systematic Comparison Approach:
Conduct parallel experiments across multiple model systems
Standardize experimental conditions and analysis methods
Use identical reagents and detection methods when possible
Include positive and negative controls relevant to each system
Sequential Hypothesis Testing:
Develop clear hypotheses explaining contradictions
Design experiments to specifically test each hypothesis
Use statistical methods appropriate for reconciling divergent data
Consider dose-response and temporal dynamics
Technical Validation:
Verify antibody specificity across species and platforms
Confirm KRT26 knockdown/overexpression efficiency
Use multiple detection methods for each finding
Assess for potential interfering factors (post-translational modifications, isoforms)
Biological Context Consideration:
Structural Comparison Analysis:
Domain Organization:
Like other type I keratins, KRT26 contains:
N-terminal head domain (variable region)
Central rod domain (conserved α-helical region)
C-terminal tail domain (variable region)
Distinguishing Features:
Specific amino acid sequences in the head and tail domains confer functional specificity
The rod domain contains heptad repeats that facilitate coiled-coil formation with type II keratins
Unique regions likely mediate specific protein-protein interactions
Implications for Functional Studies:
Mutation studies should target both conserved and unique regions
Partner identification studies should consider heterodimeric interactions
Localization studies should examine both cellular and tissue distribution
Post-translational modification sites may differ from other keratins
Researchers should design experiments that account for these structural features, potentially using domain-swapping approaches to identify regions responsible for KRT26-specific functions .
Advanced Interaction Analysis Methods:
Proximity-Based Interaction Mapping:
BioID or APEX2 proximity labeling with KRT26 as bait
In situ proximity ligation assay (PLA) for endogenous interaction detection
FRET/BRET analysis for real-time interaction dynamics
Co-Immunoprecipitation Variations:
Tandem affinity purification for high-confidence interactions
Quantitative SILAC-based co-IP for dynamic interaction mapping
Crosslinking-assisted co-IP for transient interaction capture
Structural Biology Approaches:
Cryo-EM for filament structure determination
Hydrogen-deuterium exchange mass spectrometry for interaction interfaces
Integrative structural modeling combining multiple data types
Functional Validation Techniques:
CRISPR interference/activation to modulate interactor levels
Competitive peptide inhibition to disrupt specific interactions
Domain mapping through truncation and point mutation analysis
When studying KRT26 interactions with other hair follicle proteins like trichohyalin (TCHH), these approaches can reveal both structural and functional relationships that contribute to hair shaft formation and properties .
Emerging Technologies with Potential Impact:
Single-Cell Multi-omics:
Integrated single-cell RNA-seq, ATAC-seq, and proteomics to map KRT26 regulation
Spatial transcriptomics with subcellular resolution
In situ sequencing for tissue context preservation
Advanced Genome Engineering:
Base editing for precise introduction of KRT26 variants
Prime editing for complex genetic modifications
Inducible/conditional CRISPR systems for temporal control
Tissue-specific in vivo editing approaches
Organoid and Advanced Culture Systems:
Hair follicle organoids for developmental studies
Skin-on-chip microfluidic platforms
Bioprinted skin equivalents with controlled KRT26 expression
Patient-derived organoids for personalized disease modeling
Computational Approaches:
Transgenic Model Design Strategy:
Model Selection Considerations:
Mouse models offer genetic tractability and established protocols
Larger animals (e.g., sheep, goats) provide better hair follicle parallels
Consider evolutionary conservation of KRT26 across species
Genetic Modification Approaches:
Conventional knockout for complete loss-of-function
Conditional knockout using Cre/loxP for tissue-specific deletion
Knock-in of reporter genes (GFP, LacZ) for expression tracking
Human variant knock-in for disease modeling
Experimental Design Guidelines:
Include appropriate controls (littermates, isogenic lines)
Perform comprehensive phenotyping across tissues and time points
Analyze at both macroscopic and molecular levels
Consider compensatory mechanisms and genetic background effects
Tissue-Specific Considerations:
Critical Considerations and Pitfalls:
Protein Handling Issues:
Inappropriate storage conditions leading to degradation
Excessive freeze-thaw cycles reducing protein activity
Buffer incompatibility causing precipitation or aggregation
Insufficient protein concentration for detection methods
Experimental Design Flaws:
Inadequate controls (positive, negative, isotype)
Lack of validation across multiple techniques
Insufficient replication for statistical significance
Failure to account for cross-reactivity with related keratins
Interpretation Challenges:
Over-interpretation of correlative findings as causal
Neglecting species-specific differences in keratin biology
Failing to consider developmental and context-dependent effects
Disregarding technical limitations of detection methods
Translational Considerations:
Interdisciplinary Research Framework:
Integrative Research Teams:
Dermatologists and hair biologists for phenotypic expertise
Structural biologists for keratin assembly insights
Neuroscientists for ASD-related investigations
Geneticists for variant interpretation
Bioengineers for advanced model development
Methodological Integration:
Combine genetics, genomics, and proteomics approaches
Link structural studies with functional analysis
Connect molecular findings with clinical observations
Integrate computational modeling with experimental validation
Collaborative Research Design:
Standardize protocols across research groups
Develop shared resources (antibodies, cell lines, animal models)
Establish data sharing platforms for KRT26 research
Create interdisciplinary training opportunities
Translational Approaches: